Arabic Arabic English English French French German German
dark

Philip Morris Makes $1.44 Billion Bid for UK Inhaled Drug Specialist Vectura Group 

Philip Morris will acquire Vectura to gain access to its inhaled drug formulas to bolster its Beyond Nicotine strategy. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Effect of yoga and physiotherapy on pulmonary functions in children with Duchenne muscular dystrophy.

Next Post

BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma

Related Posts
Total
0
Share